Unknown

Dataset Information

0

The angiotensin II/AT1 receptor pathway mediates malaria-induced acute kidney injury.


ABSTRACT: Malaria-induced acute kidney injury (MAKI) is a life-threatening complication of severe malaria. Here, we investigated the potential role of the angiotensin II (Ang II)/AT1 receptor pathway in the development of MAKI. We used C57BL/6 mice infected by Plasmodium berghei ANKA (PbA-infected mice), a well-known murine model of severe malaria. The animals were treated with 20 mg/kg/day losartan, an antagonist of AT1 receptor, or captopril, an angiotensin-converting enzyme inhibitor. We observed an increase in the levels of plasma creatinine and blood urea nitrogen associated with a significant decrease in creatinine clearance, a marker of glomerular flow rate, and glomerular hypercellularity, indicating glomerular injury. PbA-infected mice also presented proteinuria and a high level of urinary ?-glutamyltransferase activity associated with an increase in collagen deposition and interstitial space, showing tubule-interstitial injury. PbA-infected mice were also found to have increased fractional excretion of sodium (FENa+) coupled with decreased cortical (Na++K+)ATPase activity. These injuries were associated with an increase in pro-inflammatory cytokines, such as tumor necrosis factor alpha, interleukin-6, interleukin-17, and interferon gamma, in the renal cortex of PbA-infected mice. All modifications of these structural, biochemical, and functional parameters observed in PbA-infected mice were avoided with simultaneous treatment with losartan or captopril. Our data allow us to postulate that the Ang II/AT1 receptor pathway mediates an increase in renal pro-inflammatory cytokines, which in turn leads to the glomerular and tubular injuries observed in MAKI.

SUBMITTER: Silva LS 

PROVIDER: S-EPMC6133374 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications


Malaria-induced acute kidney injury (MAKI) is a life-threatening complication of severe malaria. Here, we investigated the potential role of the angiotensin II (Ang II)/AT1 receptor pathway in the development of MAKI. We used C57BL/6 mice infected by Plasmodium berghei ANKA (PbA-infected mice), a well-known murine model of severe malaria. The animals were treated with 20 mg/kg/day losartan, an antagonist of AT1 receptor, or captopril, an angiotensin-converting enzyme inhibitor. We observed an in  ...[more]

Similar Datasets

| S-EPMC5302058 | biostudies-literature
| S-EPMC3055735 | biostudies-literature
| S-EPMC8030124 | biostudies-literature
| S-EPMC3551944 | biostudies-literature
| S-EPMC3508356 | biostudies-literature
| S-EPMC7952713 | biostudies-literature
| S-EPMC2637079 | biostudies-literature
| S-EPMC6281047 | biostudies-literature
| S-EPMC3668713 | biostudies-literature
| S-EPMC3358757 | biostudies-literature